United States

The study finds that 17 year-olds who use e-cigarettes are more likely to use both e-cigarettes and regular cigarettes by the age of 19.

We welcome news that the Food and Drug Administration (FDA) has given five makers of popular vaping devices - Juul Labs, RJR Vapor, Altria Group, Imperial Brands and Logic – 60 days to prove they can keep their products away from minors.

The petition follows a two-year investigation, that found tobacco companies are paying young social media influencers with large audiences to post images of cigarettes and smoking and promote tobacco industry-sponsored events, contests and online promotions.

Vital Strategies has welcomed an announcement from the U.S. Food and Drug Administration (FDA) regarding its intention to decrease the burden of tobacco-related harm in the USA by regulating nicotine levels and, potentially, flavorings in tobacco products.

Vital Strategies has denounced President Trump’s decision to renege on the USA’s obligations under the Paris Climate Agreement.

Vital Strategies has congratulated authorities and health advocates in New York City on their work to introduce a series of new policies to curb tobacco use. These policies include raising the minimum price of all tobacco products and reducing through attrition the 9,000 tobacco retailers in NYC.

Vital Strategies has expressed alarm that Dr. Scott Gottlieb, the nominee for commissioner of the United States Food and Drug Administration, previously held a position with an e-cigarette company and continues to have declared financial interests in that business.

This move dismisses worldwide scientific consensus around the causes and consequences of climate change, ignores the direct benefits to public health in the US from cleaner air, and undermines the Paris Agreement.

Vital Strategies has welcomed the publication of the Surgeon General’s report into e-cigarettes in the US. Vital Strategies – like World Health Organization and others - has previously urged a precautionary approach toward e-cigarettes and called for tighter regulation of the sale and use of these products.